Banco Santander S.A. Buys 15,167 Shares of Intuitive Surgical, Inc. $ISRG

Banco Santander S.A. grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 22.5% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 82,563 shares of the medical equipment provider’s stock after buying an additional 15,167 shares during the quarter. Banco Santander S.A.’s holdings in Intuitive Surgical were worth $36,925,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ISRG. Norges Bank bought a new stake in Intuitive Surgical during the second quarter worth about $2,569,260,000. Rakuten Investment Management Inc. purchased a new position in shares of Intuitive Surgical during the 3rd quarter valued at about $388,436,000. Vanguard Group Inc. lifted its position in Intuitive Surgical by 2.1% in the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock worth $18,115,025,000 after buying an additional 670,302 shares during the last quarter. Canada Pension Plan Investment Board boosted its stake in Intuitive Surgical by 27.1% in the second quarter. Canada Pension Plan Investment Board now owns 1,089,293 shares of the medical equipment provider’s stock worth $591,933,000 after buying an additional 231,980 shares in the last quarter. Finally, Winslow Capital Management LLC grew its position in Intuitive Surgical by 20.2% during the second quarter. Winslow Capital Management LLC now owns 1,342,473 shares of the medical equipment provider’s stock valued at $729,513,000 after acquiring an additional 225,545 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the stock. Raymond James Financial boosted their price objective on shares of Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a report on Friday, January 23rd. Argus lowered their price objective on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research note on Wednesday, February 4th. Sanford C. Bernstein boosted their target price on Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a research note on Friday, January 23rd. UBS Group set a $570.00 price target on Intuitive Surgical and gave the stock a “neutral” rating in a research note on Tuesday. Finally, Robert W. Baird cut their price target on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a report on Friday, January 23rd. Two research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $615.86.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 133 shares of Intuitive Surgical stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the transaction, the vice president owned 660 shares in the company, valued at approximately $326,673.60. The trade was a 16.77% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 421 shares of the business’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $208,378.16. Following the completion of the sale, the executive vice president directly owned 409 shares in the company, valued at $202,438.64. This trade represents a 50.72% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 56,189 shares of company stock valued at $30,785,441 over the last ninety days. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Up 0.1%

ISRG opened at $506.88 on Friday. The company has a market cap of $180.01 billion, a price-to-earnings ratio of 64.24, a price-to-earnings-growth ratio of 3.90 and a beta of 1.65. The stock has a fifty day simple moving average of $531.21 and a two-hundred day simple moving average of $511.26. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. During the same period in the prior year, the firm earned $2.21 EPS. The company’s revenue was up 18.8% compared to the same quarter last year. On average, analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.